Cargando…
The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis
In non-obese diabetic (NOD) mice that spontaneously develop autoimmune diabetes, plasmacytoid dendritic cells (pDCs) have a diabetes-promoting role through IFN-α production on one hand, while a diabetes-inhibiting role through indoleamine 2,3-dioxygenase (IDO) production on the other. Little is know...
Autores principales: | Welzen-Coppens, Jojanneke M. C., van Helden-Meeuwsen, Cornelia G., Leenen, Pieter J. M., Drexhage, Hemmo A., Versnel, Marjan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555833/ https://www.ncbi.nlm.nih.gov/pubmed/23372814 http://dx.doi.org/10.1371/journal.pone.0055071 |
Ejemplares similares
-
The Gene Expression Profile of CD11c(+)CD8α(−) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse
por: Beumer, Wouter, et al.
Publicado: (2014) -
Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland
por: Wildenberg, Manon E, et al.
Publicado: (2008) -
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013) -
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014) -
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)